Lars Fruergaard Jørgensen: Former CEO of Novo Nordisk
The executive who made Ozempic and Wegovy a global pharmaceutical phenomenon and nearly tripled Novo Nordisk's revenue in eight years, before stepping down amid rising competition, supply shortages, and the CagriSema trial disappointment.
Think & Rich